Impact BioMedical Inc.
IBO
$0.46
$0.024.39%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -698.00K | -2.29M | 5.25M | -1.47M | -14.35M |
| Total Depreciation and Amortization | 284.00K | 285.00K | 286.00K | 856.00K | 288.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -568.00K | -- |
| Total Other Non-Cash Items | -1.00K | 1.44M | -5.97M | 526.00K | 13.36M |
| Change in Net Operating Assets | 885.00K | 95.00K | 541.00K | 42.00K | 6.00K |
| Cash from Operations | 470.00K | -464.00K | 99.00K | -613.00K | -694.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00K | -1.00K | 1.00K | 1.00K | 0.00 |
| Cash from Investing | 2.00K | -1.00K | 1.00K | 1.00K | 0.00 |
| Total Debt Issued | -482.00K | 482.00K | 184.00K | -- | -- |
| Total Debt Repaid | -- | -- | -293.00K | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -482.00K | 482.00K | -109.00K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.00K | 17.00K | -9.00K | -612.00K | -694.00K |